Medical And Surgical Management Of Severe Clostridium Difficile Colitis Predictors Of Poor Outcome After Intracolonic Vancomycin | 3347
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Medical and surgical management of severe Clostridium difficile colitis predictors of poor outcome after intracolonic vancomycin

2nd International Conference on Gastroenterology & Urology

Peter K. Kim

ScientificTracks Abstracts: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X.S1.012

Severe C. difficile colitis refractory to medical therapy may require surgical intervention including subtotal colectomy. We initiated an adjuvant intracolonic vancomycin (ICV) enema protocol for inpatients with severe C. difficile colitis and compared the response in patients admitted from the community and nursing homes. A single hospital, retrospective chart review was performed on 47 consecutive patients with C. difficile colitis treated with ICV (1 gram in 500 cc normal saline q 6 h) from January 2007 through October 2009. Associations of patient characteristics with outcomes (response to ICV therapy, need for surgery, and mortality) were examined with bivariate tests and multivariable logistic models adjusting for age, hypoalbuminemia, acidosis, and nursing home status. Overall, 37 of 47 patients (79%) survived after ICV therapy. Incomplete responders who had surgery were more likely to survive than those patients who did not undergo subtotal colectomy (p<0.01). Seven of 9 patients who underwent surgery survived. Nursing home residence, acidosis, and hypoalbuminemia were significantly associated with non-resolution in bivariate analysis (all p<0.01). Multivariable logistic models confirmed that acidosis correlated with incomplete response to ICV (P=0.02), and older age correlated with death (P=0.04); hypoalbuminemia correlated significantly with both incomplete response to ICV and death (P=0.04). Hypoalbuminemia is a major predictor of poor response to ICV and death from severe C. difficile colitis. Early surgery should be considered for geriatric patients who present with hypoalbuminemia and acidosis. In this discussion, we will review the current medical and surgical therapies for severe C. difficile colitis.
Peter K. Kim, M.D., FACS completed his undergraduate studies magna cum laude in Biochemistry at Harvard College, M.D. with honors in research at Weill Medical College of Cornell University, and his surgical training at the University of Pittsburgh and Mount Sinai Medical Center. He is presently Assistant Professor of Surgery at Albert Einstein College of Medicine and Jacobi Medical Center in the Bronx, NY. He specializes his work in the complex management of life-threatening surgical infections.